UGX202

· Suzhou UgeneX Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UGX202, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: UGX202 Injection in Patients With Advanced Retinitis Pigmentosa [EARLY_Phase 1]